Clinical Trials › NCT05539729
RecruitingPhase 1
Vancomycin Study in Multiple Sclerosis (MS)
Sponsored by Icahn School of Medicine at Mount Sinai
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 12
Target enrollment
1
U.S. states
Jan 2023
Start date
Sep 2026
Expected completion
Interventions / Treatments
VancomycinPlacebo
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
New York1 site
New York
Participating MS centers on MS Buddy (1)
MS centers in New York
Compare treatment centers near a trial site by center type, providers and trials.
View New York centersMore Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.